Serum Vitamin D Levels in Chronic Hepatitis B Patients Before and During Treatment

Author:

Mohamed Amal A.1ORCID,Abdo Sabry2ORCID,Said Ebada2ORCID,El Agawy Waleed3ORCID,Awad Peter4ORCID,Ghanem Ayat I.M.5ORCID,Khattab Rania A.6ORCID,El-damasy Dalia A.7ORCID,Elkadeem Mahmoud8ORCID,Abd-Elsalam Sherief8ORCID

Affiliation:

1. Biochemistry Department, National Hepatology and Tropical Medicine, Cairo, Egypt

2. Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine Banha University, Cairo, Egypt

3. Hepatology, Gastroenterology and Infectious Diseases Department, Faculty of Medicine Portsaid University, Cairo, Egypt

4. Gastroenterology and Hepatology Department, Kobry el Kobba Military Hospital, Cairo, Egypt

5. Clinical Pathology Department, National Institute of Diabetics and Endocrinology, Egypt

6. Department of Microbiology and Immunology, Faculty of Pharmacy, Cairo University, Cairo, Egypt

7. Microbiology Department, Faculty of Pharmacy, Egyptian Russian University, Badr, Egypt

8. Tropical Medicine Department, Tanta University, Tanta, Egypt

Abstract

Background & Aims: Hepatitis B is a potentially life-threatening liver infection and it is a major global health problem. Over the past decade, numerous studies have reported that patients with CLD, especially HCV-positive and HBV-positive patients, have decreased 25(OH) D levels. The current study was designed to assess the serum levels of vitamin D [25(OH) D3] in chronic hepatitis B patients, before and during treatment with antiviral therapy. Methods: It was a prospective study in which 80 subjects were enrolled between December 2017 and June 2018. A total of 50 treatment-naïve chronic HBV patients and 30 healthy subjects were recruited. The studied cases received treatment in the form of Lamivudine 100 mg tablet, once daily. Full routine laboratory investigations, HBV DNA measurement by real-time PCR were conducted once before initiation of antiviral treatment and again at least 6 months later. Serum vitamin D level [25(OH)D3 was assessed twice, once before initiation of antiviral treatment and again at least 6 months later. This was done for all the patients enrolled in the study. Results: The studied cases showed a significantly low mean serum Vitamin D level when assessed before treatment (21.6 ± 5.8 ng/ml), compared to the level after 6 ms of treatment (31.1 ± 7.3 ng/ml) which was comparable to that of the control group (33.4 ± 5 ng/ml). Conclusion: The present study highlights the impact of antiviral therapy on vitamin D deficiency in CHB patients, where effective therapy improves vitamin D levels. Meanwhile, it is recommended to study the impact of vitamin D replacement and correction on the disease progression or regression.

Publisher

Bentham Science Publishers Ltd.

Subject

Microbiology (medical),Pharmacology,Molecular Medicine,General Medicine

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3